LatchBio
Data infrastructure for biology
- 21-100 employees
- Healthcare
- B2B
- SaaS
- MedTech
- SoMa, San Francisco, CA
Jump to section
Company mission
To build and disseminate the data infrastructure of the biocomputing revolution.
Our take
Biological research innovations are leading to ever larger data heaps, and it is getting harder to analyze it all. Addressing this need, LatchBio helps to collate and analyze data from bio research using a Cloud Bioinformatics platform, end-to-end data organizer and workflow builder.
With backgrounds in big tech and data pipelining for the likes of Google and X, the founders of LatchBio implemented their skills for the rapidly evolving world of biotech, taking the weight of biocomputation off the hands of the scientists running the tests. Having closed an early Series A funding round in June 2022, the company's switch from big data companies is most definitely paying off.
LatchBio has continued to expand its platform in step with the growing demands of modern biology. The company now provides white-labelled data infrastructure and analysis tools for biotech solution providers, and has released one of the largest open-source human spatial transcriptomics atlases to date, covering millions of cells across multiple technologies, tissues, and diseases. With improved data curation and public access portals, LatchBio isn't just a workflow tool, but a central hub for large-scale biological data, helping researchers and partners move from raw data to insight faster.
Kirsty
Company Specialist at Welcome to the Jungle
Benefits
- Unlimited PTO policy
- 100%-subsidized premium on Cigna’s platinum health plan, and 75%-subsidized coverage for dependents
- Dental and vision insurance
- 401(k) plan options
- Ambitious equity incentives
- Fully-subsidized office parking
- Signing bonus and competitive compensation
- 12+ meals provided weekly
- Annual technology stipend
- Company-sponsored professional development
- O-1 visa sponsorship
- Team-wide science reading groups
Funding (2 rounds)
Jun 2022
$28m
SERIES A
Oct 2021
$5m
SEED
Total funding: $33m
This company has top investors
Leadership
Alfredo Andere
(Co-Founder & CEO)Previously the President of Machine Learning at Berkeley, a Software Engineer at Google, and a Data Engineer at Facebook.
Kenny Workman
(Co-Founder & CTO)Previously a Machine Learning Engineer at Serotiny, a Software Engineer at Asimov, and a Researcher at Agile Biofoundry.
Kyle Goffin
(Co-Founder & COO)Previously the Editor in Chief at UC Berkeley Sutardja Center for Entrepreneurship and Technology, a Research and Publications Lead at Neurotech@Berkeley, and an Independent Analyst at DelMorgan & Co.